MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$30,060,333
Change in fair value of
kineta merger holdback...
$1,590,949
Grant income
$713,508
Interest income
$136,233
Employee retention tax
credit
$113,574
Net loss
-$30,051,977
Series a preferred cash
dividend
$8,356
Total other income
(expense)
$1,743,962
Interest expense
$625,283
Loss on kineta
employee separation...
$185,019
Operating loss
$31,795,939
Research and development
expenses
$20,532,670
General and
administrative expenses
$7,583,651
Acquisition-related costs (note 5)
$3,679,618
Back
Back
Income Statement
source: myfinsight.com
TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)